These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 16263185)

  • 1. Apelin: a new plasma marker of cardiopulmonary disease.
    Goetze JP; Rehfeld JF; Carlsen J; Videbaek R; Andersen CB; Boesgaard S; Friis-Hansen L
    Regul Pept; 2006 Jan; 133(1-3):134-8. PubMed ID: 16263185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of plasma apelin and other indices of cardiac dysfunction in the clinical assessment of patients with dilated cardiomyopathy.
    Miettinen KH; Magga J; Vuolteenaho O; Vanninen EJ; Punnonen KR; Ylitalo K; Tuomainen P; Peuhkurinen KJ
    Regul Pept; 2007 May; 140(3):178-84. PubMed ID: 17223209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discriminating between cardiac and pulmonary dysfunction in the general population with dyspnea by plasma pro-B-type natriuretic peptide.
    Mogelvang R; Goetze JP; Schnohr P; Lange P; Sogaard P; Rehfeld JF; Jensen JS
    J Am Coll Cardiol; 2007 Oct; 50(17):1694-701. PubMed ID: 17950153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-terminal pro-B-type natriuretic peptide as an indicator of disease severity in a heterogeneous group of patients with chronic precapillary pulmonary hypertension.
    Andreassen AK; Wergeland R; Simonsen S; Geiran O; Guevara C; Ueland T
    Am J Cardiol; 2006 Aug; 98(4):525-9. PubMed ID: 16893710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B-type natriuretic peptide and its molecular precursor in myocardial infarction complicated by cardiogenic shock.
    Hejmdal A; Boesgaard S; Lindholm MG; Goetze JP
    J Card Fail; 2007 Apr; 13(3):184-8. PubMed ID: 17448415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain natriuretic peptide as noninvasive marker of the severity of right ventricular dysfunction in chronic thromboembolic pulmonary hypertension.
    Reesink HJ; Tulevski II; Marcus JT; Boomsma F; Kloek JJ; Vonk Noordegraaf A; Bresser P
    Ann Thorac Surg; 2007 Aug; 84(2):537-43. PubMed ID: 17643631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased apelin following bone marrow mononuclear cell transplantation contributes to the improvement of cardiac function in patients with severe heart failure.
    Gao LR; Xu RY; Zhang NK; Chen Y; Wang ZG; Zhu ZM; Fei YX; Cao Y; Xu HT; Yang Y
    Cell Transplant; 2009; 18(12):1311-8. PubMed ID: 19785937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of plasma N-terminal pro-brain natriuretic peptide (NT-proBNP) to distinguish between congestive heart failure and non-cardiac causes of acute dyspnea in cats.
    Fox PR; Oyama MA; Reynolds C; Rush JE; DeFrancesco TC; Keene BW; Atkins CE; Macdonald KA; Schober KE; Bonagura JD; Stepien RL; Kellihan HB; Nguyenba TP; Lehmkuhl LB; Lefbom BK; Moise NS; Hogan DF
    J Vet Cardiol; 2009 May; 11 Suppl 1():S51-61. PubMed ID: 19394287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma concentrations of the novel peptide apelin are decreased in patients with chronic heart failure.
    Chong KS; Gardner RS; Morton JJ; Ashley EA; McDonagh TA
    Eur J Heart Fail; 2006 Jun; 8(4):355-60. PubMed ID: 16464638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amino-terminal pro-brain natriuretic peptide for the diagnosis of acute heart failure in patients with previous obstructive airway disease.
    Tung RH; Camargo CA; Krauser D; Anwaruddin S; Baggish A; Chen A; Januzzi JL
    Ann Emerg Med; 2006 Jul; 48(1):66-74. PubMed ID: 16781921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
    von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD
    J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased plasma concentrations of N-terminal pro-B-type natriuretic peptide in patients with mild primary hyperparathyroidism.
    Almqvist EG; Becker C; Bondeson AG; Bondeson L; Svensson J; Svensson SE
    Clin Endocrinol (Oxf); 2006 Dec; 65(6):760-6. PubMed ID: 17121527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alternate circulating pro-B-type natriuretic peptide and B-type natriuretic peptide forms in the general population.
    Lam CS; Burnett JC; Costello-Boerrigter L; Rodeheffer RJ; Redfield MM
    J Am Coll Cardiol; 2007 Mar; 49(11):1193-202. PubMed ID: 17367664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of azotemia on serum N-terminal proBNP concentration in dogs with normal cardiac function: a pilot study.
    Schmidt MK; Reynolds CA; Estrada AH; Prosek R; Maisenbacher HW; Sleeper MM; Oyama MA
    J Vet Cardiol; 2009 May; 11 Suppl 1():S81-6. PubMed ID: 19394913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B-type natriuretic peptide (BNP) and N-terminal-proBNP for heart failure diagnosis in shock or acute respiratory distress.
    Bal L; Thierry S; Brocas E; Van de Louw A; Pottecher J; Hours S; Moreau MH; Perrin Gachadoat D; Tenaillon A
    Acta Anaesthesiol Scand; 2006 Mar; 50(3):340-7. PubMed ID: 16480468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic value of N-terminal pro-B-type natriuretic peptide (NT-proBNP) for left ventricular dysfunction in patients with chronic kidney disease stage 5 on haemodialysis.
    David S; Kümpers P; Seidler V; Biertz F; Haller H; Fliser D
    Nephrol Dial Transplant; 2008 Apr; 23(4):1370-7. PubMed ID: 18089624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can pro-brain natriuretic peptide be used as a noninvasive predictor of elevated left ventricular diastolic pressures in patients with normal systolic function?
    Joung B; Ha JW; Ko YG; Kang SM; Rim SJ; Jang Y; Chung N; Shim WH; Cho SY
    Am Heart J; 2005 Dec; 150(6):1213-9. PubMed ID: 16338261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of N-terminal pro-brain natriuretic peptide to detect acute cardiac dysfunction during weaning failure in difficult-to-wean patients with chronic obstructive pulmonary disease.
    Grasso S; Leone A; De Michele M; Anaclerio R; Cafarelli A; Ancona G; Stripoli T; Bruno F; Pugliese P; Dambrosio M; Dalfino L; Di Serio F; Fiore T
    Crit Care Med; 2007 Jan; 35(1):96-105. PubMed ID: 17095948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pro-B-type natriuretic peptide levels in acute decompensated heart failure.
    Waldo SW; Beede J; Isakson S; Villard-Saussine S; Fareh J; Clopton P; Fitzgerald RL; Maisel AS
    J Am Coll Cardiol; 2008 May; 51(19):1874-82. PubMed ID: 18466803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myocardial apelin production is reduced in humans with left ventricular systolic dysfunction.
    Chandrasekaran B; Kalra PR; Donovan J; Hooper J; Clague JR; McDonagh TA
    J Card Fail; 2010 Jul; 16(7):556-61. PubMed ID: 20610231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.